Aquestive Therapeutics
AQST
AQST
174 hedge funds and large institutions have $466M invested in Aquestive Therapeutics in 2025 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 151 → 174 (+23)
11% more call options, than puts
Call options by funds: $12.6M | Put options by funds: $11.4M
7.14% less ownership
Funds ownership: 66.26% → 59.11% (-7.1%)
Holders
174
Holding in Top 10
4
Calls
$12.6M
Puts
$11.4M
Top Buyers
| 1 | +$7.79M | |
| 2 | +$7.78M | |
| 3 | +$7.19M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$6.59M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.05M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$4.52M | |
| 3 | -$3.35M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$3.15M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.12M |
